Page 91 - Micron News Today

The FDA has authorized additional omicron bivalent booster doses for people 65 and older and those with compromised immune systems, the agency said April 18. 

Omicron subvariant XBB.1.16 has caused a spike in infections in India, causing mask mandate to be reintroduced.

Researchers evaluated whether bivalent mRNA vaccine booster reduced COVID-19-related hospitalizations and mortality.

Researchers designed a novel messenger ribonucleic acid (mRNA) vaccine component designated BNT162b4.

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

A microchip manufacturing facility planned for a nearby county could prompt workers to settle down in surrounding areas, and Jenny Haines is among a group of officials and professionals working

Researchers evaluated humoral responses to severe acute respiratory syndrome coronavirus 2 in infants.

Researchers investigate whether SARS-CoV-2 and its variants have evolved to evade CD8+ T cell-mediated immunity.

Researchers examined the effectiveness of SARS-CoV-2 booster doses in preventing severe Omicron infection outcomes.

A total of 54 cases of Omicron subvariant XBB.1.9.1 have been detected in the Philippines, according to the Department of Health (DOH).